MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .
Collaborative study looks for clues on hard-to-treat breast cancer - Medical Xpress
Collaborative study looks for clues on hard-to-treat breast cancerMedical XpressSome types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy.
Collaborative study looks for clues on hard-to-treat breast cancer - R & D Magazine
R & D MagazineCollaborative study looks for clues on hard-to-treat breast cancerR & D MagazineSome types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy.
The Downside of Chemoprevention for Breast Cancer - Medscape
The Downside of Chemoprevention for Breast CancerMedscapeIn this study, both tamoxifen and raloxifene were shown to be effective in reducing breast cancer risk.
MicroRNAs in breast cancer play a role in development of resistance to tamoxifen - News-Medical.net
MicroRNAs in breast cancer play a role in development of resistance to tamoxifenNews-Medical.